Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO ‐ PROFIT study
Authors' conclusion
The AUSTRO-PROFIT study revealed notable variations in metabolic targets achievement with respect to clinical characteristics and comorbidities. These findings underscore the importance of establishing national diabetes registries and implementing multifactorial targeted and individualized interventions to further improve the quality of T2D care in primary care settings in Austria.
Study context
- Population
- Individuals with T2D treated in primary care in Austria, 2021–2023; mean age 65.7 ± 11.2 years, median T2D duration 8 (4–14) years, 58.7% male
- Participants
- 635 individuals
- Outcome
- Achievement of metabolic risk factor targets: LDL-C <70 mg/dL (or < 55 mg/dL with cardiovascular or microvascular disease), HbA1c <7% (53 mmol/mol), blood pressure < 140/90 mmHg
Methodological detailscountrywide
- Countrywide
Main finding
As reported in the abstract
Proportion achieving targets
Low-density lipoprotein cholesterol (LDL-C) target achieved
44%
HbA1c target achieved
53%
Blood pressure target achieved
57%
All targets achieved
13%
Observational data: associations, not effects.
Further findings
Factors associated with target achievement
- Older age, longer T2D duration, CVD and microvascular complications were associated with suboptimal achievement of targets
Original publication
Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO ‐ PROFIT study. Diabetes Obes Metab. Published 3 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →